It’s part of a whole PR campaign.
Here’s your daily dose of pot news from the newsletter WeedWeek.
Ahead of his confirmation hearing for Attorney General, a public relations campaign is trying to depict Sen. Jeff Sessions as emphatically not a racist. He has long been dogged by such accusations, due in part to a statement that he was ok with the Ku Klux Klan, until he heard that they smoke pot.
Rolling Stone envisions the war on drugs under Attorney General Sessions.
Oregon is revising its product testing rules again, following complaints from companies. Nevada companies call for strict product testing.
The Democrat and Chronicle (Rochester, N.Y.) reports on “ progress and hurdles” in the New York MED program. For more see here.
Maine REC opponents cancelled their recall effort. Gov. Paul LePage (R) said that with REC there’s no longer a need for a MED program. A prominent New Hampshire state senator will propose a REC bill.
Canada.com looks at how legalization up north could alter Canadian/American relations.
An Arizona judge ruled that local officials can’t use federal law to block MED dispensaries.
The city of Copenhagen is pursuing a longshot legalization push in an effort to reduce gang warfare.
Caribbean nation Dominica will consider MED legalization next year.
Denver cannabis law firm Hoban Law Group may sue the DEA over its recent CBD ruling.
Purdue Pharma, which makes Oxycontin, is expanding overseas. In the U.S., the L.A. Times remarks, opioids are a “dying business.”
Hound Labs and Cannabix Technologies are racing to perfect a cannabis breathalyzer.
Boston is another potential “ cannabis capital.” Canadian businesses are preparing for legalization.
CBD pet treats are becoming big business.
Older adults are using more cannabis, and binge drinking more too. Cannabis use may not be a good idea for those seeking long-term abatement of depression and anxiety, Colorado researchers found.
Modern Farmer hangs out with Bear Real, a Colorado hemp scientist.